Список проголосовавших за комментарий " <table class="BriefingDataTable" border="0" cellspacing="0" cellpadding="0"><tr> <td class="tickerColumn"> </td> <td class="articleColumn">Stryker target raised to $137 at Canaccord Genuity following earnings; Buy (123.40 +1.90)Canaccord Genuity raises their SYK tgt to $137 from $127 after reporting quarterly results noting, «Net net, our conviction remains for mid-single-digit organic revenue growth and opportunity for upside to operating margins given expectations for 30-50 bps OM margin expansion annually. <strong>While the full market release of the MAKO knee is likely to capture the majority of investor interest in 2017, we note Stryker continues to perform with strong growth across key global markets and enters 2017 on the cusp of major new product cycles in hips and MedSurg.»</strong></td> </tr></table>"